Sunho Biologics Inc (2898.HK)

HKD 4.04

(0.0%)

EBITDA Summary of Sunho Biologics Inc

  • Sunho Biologics Inc's latest annual EBITDA in 2023 was -123.36 Million CNY , down -67.17% from previous year.
  • Sunho Biologics Inc's latest quarterly EBITDA in 2024 Q2 was -24.78 Million CNY , down 0.0% from previous quarter.
  • Sunho Biologics Inc reported an annual EBITDA of -38.1 Million CNY in 2022, up 41.84% from previous year.
  • Sunho Biologics Inc reported an annual EBITDA of -64.21 Million CNY in 2021, down 0.0% from previous year.
  • Sunho Biologics Inc reported a quarterly EBITDA of -24.78 Million CNY for 2024 Q2, down 0.0% from previous quarter.
  • Sunho Biologics Inc reported a quarterly EBITDA of 5.58 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Sunho Biologics Inc (2023 - 2021)

Historical Annual EBITDA of Sunho Biologics Inc (2023 - 2021)

Year EBITDA EBITDA Growth
2023 -123.36 Million CNY -67.17%
2022 -38.1 Million CNY 41.84%
2021 -64.21 Million CNY 0.0%

Peer EBITDA Comparison of Sunho Biologics Inc

Name EBITDA EBITDA Difference